Total Payments
$4,481
2024 Payments
$330.16
Companies
49
Transactions
221
Medicare Patients
508
Medicare Billing
$67,085
Payment Breakdown by Category
Food & Beverage$4,432 (98.9%)
Education$49.19 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,432 | 217 | 98.9% |
| Education | $49.19 | 4 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $507.21 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $351.03 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $330.14 | 16 | $0 (2024) |
| Eisai Inc. | $295.84 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $235.52 | 9 | $0 (2023) |
| PFIZER INC. | $200.00 | 11 | $0 (2024) |
| Celgene Corporation | $189.69 | 9 | $0 (2023) |
| Amgen Inc. | $184.62 | 10 | $0 (2023) |
| Genentech USA, Inc. | $176.95 | 9 | $0 (2023) |
| Coherus Biosciences Inc. | $157.16 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.16 | 16 | Tempus AI, Inc ($128.79) |
| 2023 | $1,778 | 81 | Eisai Inc. ($192.69) |
| 2022 | $1,702 | 85 | Novartis Pharmaceuticals Corporation ($233.61) |
| 2021 | $186.40 | 4 | Coherus Biosciences Inc. ($157.16) |
| 2019 | $12.49 | 1 | PFIZER INC. ($12.49) |
| 2018 | $37.63 | 3 | EMD Serono, Inc. ($12.85) |
| 2017 | $434.01 | 31 | Novartis Pharmaceuticals Corporation ($112.99) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 2 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Oncology | ||||||
| 09/15/2023 | PFIZER INC. | BOSULIF (Drug), BESPONSA, ELREXFIO | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 09/12/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Oncology | ||||||
| 09/11/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
| 08/25/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: Oncology | ||||||
| 08/22/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $17.83 | General |
| Category: Interventional Oncology | ||||||
| 08/16/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 08/02/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $16.12 | General |
| Category: Oncology | ||||||
| 08/01/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Oncology | ||||||
| 07/27/2023 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Oncology | ||||||
| 07/19/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Oncology | ||||||
| 07/19/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.75 | General |
| Category: Oncology | ||||||
| 07/13/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Oncology | ||||||
| 07/07/2023 | Novartis Pharmaceuticals Corporation | TABRECTA (Drug) | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Oncology | ||||||
| 07/06/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 06/30/2023 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $62.20 | General |
| Category: Oncology | ||||||
| 06/28/2023 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $31.74 | General |
| Category: Hematology | ||||||
| 06/21/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Hematology | ||||||
| 06/09/2023 | Genentech USA, Inc. | Polivy (Biological), Tecentriq | Food and Beverage | In-kind items and services | $30.01 | General |
| Category: BioOncology | ||||||
| 06/09/2023 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $0.21 | General |
| Category: BioOncology | ||||||
| 06/06/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $17.83 | General |
| 05/31/2023 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $31.17 | General |
| Category: Oncology | ||||||
| 05/30/2023 | PFIZER INC. | BOSULIF (Drug), BESPONSA, PAXLOVID | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 05/19/2023 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: HEMATOLOGY | ||||||
| 05/16/2023 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $17.25 | General |
| Category: Interventional Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 155 | 227 | $77,610 | $24,410 |
| 2022 | 6 | 170 | 230 | $80,210 | $26,142 |
| 2021 | 6 | 114 | 141 | $42,726 | $11,961 |
| 2020 | 2 | 69 | 82 | $12,133 | $4,572 |
Total Patients
508
Total Services
680
Medicare Billing
$67,085
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 105 | $32,970 | $10,441 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 52 | $21,892 | $7,085 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 46 | $9,752 | $3,329 | 34.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $7,200 | $2,133 | 29.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $5,796 | $1,421 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 107 | $33,598 | $11,077 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 50 | $21,050 | $7,400 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 33 | $6,996 | $2,352 | 33.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $7,200 | $2,222 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $7,245 | $1,876 | 25.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $4,121 | $1,215 | 29.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 23 | $10,511 | $3,520 | 33.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 26 | $9,666 | $2,555 | 26.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $8,069 | $2,149 | 26.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 27 | $7,075 | $1,918 | 27.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $6,413 | $1,586 | 24.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 20 | 31 | $992.00 | $233.10 | 23.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 63 | $9,851 | $3,959 | 40.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 19 | $2,282 | $612.66 | 26.8% |
About Dr. Niravkumar Naik, M.D
Dr. Niravkumar Naik, M.D is a Internal Medicine healthcare provider based in Baytown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447319512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niravkumar Naik, M.D has received a total of $4,481 in payments from pharmaceutical and medical device companies, with $330.16 received in 2024. These payments were reported across 221 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($4,432).
As a Medicare-enrolled provider, Naik has provided services to 508 Medicare beneficiaries, totaling 680 services with total Medicare billing of $67,085. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Hematology
- Location Baytown, TX
- Active Since 12/06/2006
- Last Updated 12/22/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1447319512
Products in Payments
- KISQALI (Drug) $260.21
- OPDIVO (Biological) $229.13
- ZEJULA (Drug) $166.41
- Lenvima (Drug) $163.53
- Udenyca (Biological) $157.16
- IMFINZI (Biological) $149.09
- Pomalyst (Drug) $142.52
- LONSURF (Drug) $141.97
- BOSULIF (Drug) $138.08
- XT CDX (Device) $128.79
- KEYTRUDA (Biological) $88.66
- PADCEV (Biological) $86.47
- Trodelvy (Drug) $75.88
- CALQUENCE (Drug) $73.88
- OPDUALAG (Drug) $72.63
- Vonjo (Drug) $72.34
- IMBRUVICA (Drug) $71.90
- XPOVIO (Drug) $71.68
- LUMAKRAS (Drug) $68.94
- ENHERTU (Drug) $56.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Baytown
Dr. Dinara Rose, M.d, M.D
Internal Medicine — Payments: $7,729
Internal Medicine $7,729
Dr. Luis Gonzalez, M.d, M.D
Internal Medicine — Payments: $6,904
Internal Medicine $6,904
Atif Qureshi, M.d, M.D
Internal Medicine — Payments: $6,870
Internal Medicine $6,870
Shehzad Sami, Md, MD
Internal Medicine — Payments: $5,864
Internal Medicine $5,864
Kamran Khan, Md, MD
Internal Medicine — Payments: $4,512
Internal Medicine $4,512
Shehpar Khan, M.d, M.D
Internal Medicine — Payments: $4,172
Internal Medicine $4,172